RNAi therapeutic strategies for acute respiratory distress syndrome

被引：19
|
作者：
Jagrosse, Melissa L. [1 ]
Dean, David A. [2 ]
Rahman, Arshad [2 ]
Nilsson, Bradley L. [1 ]
机构：
[1] Univ Rochester, Dept Chem, Rochester, NY 14627 USA
[2] Univ Rochester, Sch Med & Dent, Dept Pediat & Neonatol, Rochester, NY USA
来源：
TRANSLATIONAL RESEARCH | 2019年 / 214卷
基金：
美国国家卫生研究院;
关键词：
ACUTE LUNG INJURY; CELL-PENETRATING-PEPTIDE; METERED-DOSE INHALER; NF-KAPPA-B; SMALL INTERFERING RNA; POSITIVE-PRESSURE VENTILATION; EXTRACORPOREAL CO2 REMOVAL; CHRONIC ALCOHOL-ABUSE; IN-VIVO; SIRNA DELIVERY;
D O I：
10.1016/j.trsl.2019.07.011
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Acute respiratory distress syndrome (ARDS), replacing the clinical term acute lung injury, involves serious pathophysiological lung changes that arise from a variety of pulmonary and nonpulmonary injuries and currently has no pharmacological therapeutics. RNA interference (RNAi) has the potential to generate therapeutic effects that would increase patient survival rates from this condition. It is the purpose of this review to discuss potential targets in treating ARDS with RNAi strategies, as well as to outline the challenges of oligonucleotide delivery to the lung and tactics to circumvent these delivery barriers.
引用
收藏
页码：30 / 49
页数：20
相关论文
共 50 条
  • [1] Non-specialist therapeutic strategies in acute respiratory distress syndrome
    Longobardo, Alessia
    Snow, Timothy A.
    Tam, Karen
    Singer, Mervyn
    Bellingan, Geoff
    Arulkumaran, Nishkantha
    MINERVA ANESTESIOLOGICA, 2021, 87 (07) : 803 - 816
  • [2] Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies
    Ma, Wen
    Tang, Songling
    Yao, Peng
    Zhou, Tingyuan
    Niu, Qingsheng
    Liu, Peng
    Tang, Shiyuan
    Chen, Yao
    Gan, Lu
    Cao, Yu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [3] Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies
    Xie, Rongli
    Tan, Dan
    Liu, Boke
    Xiao, Guohui
    Gong, Fangchen
    Zhang, Qiyao
    Qi, Lei
    Zheng, Sisi
    Yuan, Yuanyang
    Yang, Zhitao
    Chen, Ying
    Fei, Jian
    Xu, Dan
    MEDCOMM, 2025, 6 (02):
  • [4] Therapeutic Hypothermia for Acute Respiratory Distress Syndrome
    White, Heath Douglas
    Ghamande, Shekhar
    Arroliga, Alejandro C.
    CRITICAL CARE MEDICINE, 2017, 45 (11) : E1202 - E1203
  • [5] Extracorporeal Strategies in Acute Respiratory Distress Syndrome
    Cavayas, Yiorgos Alexandros
    Thakore, Aneesh
    Fan, Eddy
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 40 (01) : 114 - 128
  • [6] Immunomodulating strategies in acute respiratory distress syndrome
    Dubois, MJ
    Vincent, JL
    ETIOLOGY AND TREATMENT OF ACUTE LUNG INJURY: FROM BENCH TO BEDSIDE, 2001, 336 : 19 - 28
  • [7] Therapeutic Hypothermia for Acute Respiratory Distress Syndrome replies
    Hasday, Jeffrey D.
    CRITICAL CARE MEDICINE, 2017, 45 (11) : E1203 - E1203
  • [8] Is Therapeutic Hypothermia for Acute Respiratory Distress Syndrome the Future?
    Hayek, Adam J.
    White, Heath D.
    Ghamande, Shekhar
    Spradley, Christopher
    Arroliga, Alejandro C.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2017, 32 (07) : 460 - 464
  • [9] Simvastatin as a Potential Therapeutic for Acute Respiratory Distress Syndrome
    Shyamsundar, Murali
    O'Kane, C. M.
    McAuley, Daniel F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (10) : 1031 - 1032
  • [10] Optimal Strategies for Severe Acute Respiratory Distress Syndrome
    Cannon, Jeremy W.
    Gutsche, Jacob T.
    Brodie, Daniel
    CRITICAL CARE CLINICS, 2017, 33 (02) : 259 - +
12345